Sanket Mehta

767 total citations
40 papers, 473 citations indexed

About

Sanket Mehta is a scholar working on Surgery, Reproductive Medicine and Emergency Medicine. According to data from OpenAlex, Sanket Mehta has authored 40 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Surgery, 23 papers in Reproductive Medicine and 22 papers in Emergency Medicine. Recurrent topics in Sanket Mehta's work include Intraperitoneal and Appendiceal Malignancies (31 papers), Ovarian cancer diagnosis and treatment (22 papers) and Appendicitis Diagnosis and Management (18 papers). Sanket Mehta is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (31 papers), Ovarian cancer diagnosis and treatment (22 papers) and Appendicitis Diagnosis and Management (18 papers). Sanket Mehta collaborates with scholars based in India, France and United States. Sanket Mehta's co-authors include Aditi Bhatt, F. Quénet, Praveen Kammar, Snita Sinukumar, Diane Goèré, Frédéric Dumont, Dominique Élias, B. Saint‐Aubert, Lise Roca and Shabber Zaveri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Surgery.

In The Last Decade

Sanket Mehta

39 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanket Mehta India 12 426 262 236 55 41 40 473
Sebastián Rufián‐Peña Spain 13 450 1.1× 232 0.9× 206 0.9× 121 2.2× 61 1.5× 39 523
Alberto Gómez Portilla Spain 7 306 0.7× 171 0.7× 136 0.6× 91 1.7× 51 1.2× 23 379
Florian Struller Germany 13 418 1.0× 217 0.8× 143 0.6× 95 1.7× 49 1.2× 22 496
Delphine Vaudoyer France 13 669 1.6× 354 1.4× 280 1.2× 178 3.2× 35 0.9× 18 732
Geert A. Simkens Netherlands 13 471 1.1× 321 1.2× 160 0.7× 49 0.9× 58 1.4× 26 501
Gloria Ortega‐Pérez Spain 10 338 0.8× 167 0.6× 121 0.5× 111 2.0× 78 1.9× 18 417
Maria Rosaria Balestra Italy 7 339 0.8× 234 0.9× 171 0.7× 104 1.9× 37 0.9× 9 388
K. Abboud France 9 446 1.0× 185 0.7× 256 1.1× 85 1.5× 19 0.5× 16 480
Paul Fulford United Kingdom 12 347 0.8× 209 0.8× 194 0.8× 95 1.7× 16 0.4× 20 392
Shouzou Sako Japan 11 310 0.7× 131 0.5× 150 0.6× 109 2.0× 23 0.6× 30 354

Countries citing papers authored by Sanket Mehta

Since Specialization
Citations

This map shows the geographic impact of Sanket Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanket Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanket Mehta more than expected).

Fields of papers citing papers by Sanket Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanket Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanket Mehta. The network helps show where Sanket Mehta may publish in the future.

Co-authorship network of co-authors of Sanket Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Sanket Mehta. A scholar is included among the top collaborators of Sanket Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanket Mehta. Sanket Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhatt, Aditi, Sanket Mehta, & Olivier Gléhen. (2024). Do all patients that undergo a ‘complete’ secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer, benefit from it?. SHILAP Revista de lepidopterología. 9(3). 93–105. 1 indexed citations
3.
Bhatt, Aditi, et al.. (2024). Two-stage cytoreductive surgery for ‘extensive’ pseudomyxoma peritonei: A legitimate alternative or salvage strategy?. European Journal of Surgical Oncology. 50(10). 108593–108593. 1 indexed citations
4.
Mehta, Sanket, et al.. (2022). Venous thromboembolism prophylaxis with low molecular weight heparin versus unfractionated heparin for patients undergoing operative treatment of closed femoral shaft fractures. Journal of Clinical Orthopaedics and Trauma. 31. 101949–101949. 2 indexed citations
5.
Bhatt, Aditi, Snita Sinukumar, Vahan Képénékian, et al.. (2022). Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer. Frontiers in Oncology. 12. 951419–951419. 1 indexed citations
6.
Mehta, Sanket, et al.. (2022). Feasibility and Safety of Taxane-PIPAC in Patients with Peritoneal Malignancies—a Retrospective Bi-institutional Study. Indian Journal of Surgical Oncology. 14(S1). 166–174. 4 indexed citations
8.
Sinukumar, Snita, et al.. (2021). Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer. European Journal of Surgical Oncology. 47(6). 1427–1433. 9 indexed citations
10.
Bhatt, Aditi, Naoual Bakrin, Praveen Kammar, et al.. (2020). Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications. European Journal of Surgical Oncology. 47(1). 181–187. 11 indexed citations
12.
Bhatt, Aditi, Yutaka Yonemura, Sanket Mehta, et al.. (2020). The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors. Annals of Surgical Oncology. 27(8). 2985–2996. 45 indexed citations
14.
Sinukumar, Snita, Sanket Mehta, M. D. Ray, et al.. (2019). Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO. Indian Journal of Surgical Oncology. 10(S1). 65–70. 21 indexed citations
15.
Bhatt, Aditi, Praveen Kammar, Sanket Mehta, et al.. (2019). Chasing Rainbows? the Possibility of “Cure” in Patients with Colorectal Peritoneal Metastases Undergoing Cytoreductive Surgery and HIPEC—a Retrospective Study by INDEPSO. Indian Journal of Surgical Oncology. 10(S1). 49–56. 8 indexed citations
16.
Sinukumar, Snita, Sanket Mehta, Shabber Zaveri, et al.. (2019). Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication—a Retrospective Study by INDEPSO. Indian Journal of Surgical Oncology. 10(S1). 71–79. 12 indexed citations
17.
Bhatt, Aditi, et al.. (2019). The Current Status of Peritoneal Surface Oncology in India. Indian Journal of Surgical Oncology. 10(S1). 41–48. 3 indexed citations
18.
Mehta, Sanket, et al.. (2018). Epidural hematoma: Vigilance beyond guidelines. Indian Journal of Critical Care Medicine. 22(7). 555–557. 5 indexed citations
19.
Bhatt, Aditi, Sanket Mehta, Ramakrishnan Ayloor Seshadri, et al.. (2016). The Initial Indian Experience with Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian Journal of Surgical Oncology. 7(2). 160–165. 7 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026